Skip to content

H2020HORIZONFP7

Region Stockholm

Country
SESweden
Projects
64
As coordinator
3
EU contribution (CORDIS)
EUR 22,932,143
Active
2008 to 2025

Projects

64 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
InSilicoHealthInSilicoHealth- Training the virtual twin professionals to support healthy ageingHORIZON2025Associated partnerEUR 0
PredictAYAPrediction and prevention of late effects in AYA cancer survivors – An effort to understand, predict and prevent late effects in AYAs 15-39 years of age, with a focus on fertility and gonadal toxicityHORIZON2025ParticipantEUR 210,279
MDR-RADefining Clinical and Molecular Phenotypes of Multi-Drug Resistance in difficult to treat Rheumatoid ArthritisHORIZON2025ParticipantEUR 103,012
JOIN4ATMPMAP, JOIN AND DRIVE EUROPEAN ACTIVITIES FOR ADVANCED THERAPY MEDICINAL PRODUCT DEVELOPMENT AND IMPLEMENTATION FOR PATIENT AND SOCIETY BENEFITHORIZON2024ParticipantEUR 107,031
ERDERAEUROPEAN RARE DISEASES RESEARCH ALLIANCEHORIZON2024ParticipantEUR 18,938
TETRISRisk assessment Tools for severe side Effects after breasT Radiotherapy: radiation safety through biological extended models and dIgital twinSHORIZON2024ParticipantEUR 496,844
ENDEAVOREndoscopic brush cytology and single cell clinal dynamics of early easophageal adenocarcinoma for detecting cost effective surveillance strategies and prediction of cancer recurrenceHORIZON2024ParticipantEUR 501,563
AD-RIDDLEREAL-WORLD IMPLEMENTATION, DEPLOYMENT AND VALIDATION OF EARLY DETECTION TOOLS AND LIFESTYLE ENHANCEMENTHORIZON2024CoordinatorEUR 2,932,750
PREVENTABLECANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLEHORIZON2023ParticipantEUR 0
WISDOMWell-being improvement through the Integration of healthcare and reSearch Data and models with Out border for chronic iMmune-mediated diseasesHORIZON2023Third partyNot stated
BIOTOOL-CHFBIOmarker based diagnostic TOOLkit to personalize pharmacological approaches in congestive heart failureHORIZON2023ParticipantEUR 364,693
PROMINENTPRECISION MEDICINE PLATFORM IN NEURODEGENERATIVE DISEASEHORIZON2023ParticipantEUR 462,125
R4CRegions4ClimateHORIZON2023ParticipantEUR 305,500
PragmaTILPragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumorsHORIZON2023ParticipantEUR 912,219
GUIDE.MRDGUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRDHORIZON2023ParticipantEUR 853,336
CCI4EUCOMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPEHORIZON2023Third partyNot stated
ECHoSEstablishing of Cancer Mission Hubs: Networks and SynergiesHORIZON2023ParticipantEUR 189,564
STRATUM3D Decision Support Tool for Brain Tumor SurgeryHORIZON2023ParticipantEUR 853,125
IntReALL 2020International Study for Treatment of Childhood Relapsed ALL 2020HORIZON2023ParticipantEUR 158,750
STRATA-FITStratification of Rheumatoid Arthritis: CompuTational models to personalise mAnagement strategies for difFIcult-to-Treat diseaseHORIZON2023ParticipantEUR 155,663

The country is the one the source records for the organisation’s registration (its PIC). A body with sites in several countries is recorded under one of them, which is not always its legal seat: the Spanish research council CSIC, for example, appears under Italy. The data holds no country per site, so we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.